TrialProceedings of the National Academy of Sciences of the United States of America2018

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).

Marcin Kowanetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.